Podcasts about glp1

The finale of RHOP three part reuinon was so....mercurial that we had to find some hot topics to jabber about. FOLLOW KENDRICK: https://www.instagram.com/withkendricktucker/?hl=enLISTEN TO HIS PODCAST: https://podcasts.apple.com/gm/podcast/i-ken-not-with-kendrick-tucker/id1525311067Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Selon l'OMS, l'obésité touche aujourd'hui plus d'un milliard de personnes dans le monde, et a entrainé 3,7 millions de décès dans le monde en 2024. Maladie chronique, l'obésité est également une maladie multifactorielle dont les causes peuvent être génétiques, environnementales, neurobiologiques... Comment expliquer l'augmentation exponentielle du nombre de personnes touchées par l'obésité ? Quelles peuvent être les conséquences sur la santé ? Quelles prises en charge existent ?  À l'occasion de la journée mondiale de lutte contre l'obésité, nous allons parler de la prise en charge de cette maladie à la fois complexe, liée à des facteurs multiples et variés. L'obésité implique de multiples défis pour les patients concernés : faire face aux conséquences potentiellement nombreuses de ce surpoids pour leur santé (pour le cœur, les articulations, en termes de santé respiratoire ou de fertilité) et surmonter le jugement des autres ainsi qu'un certain nombre de contrevérités au sujet de leur état. L'obésité est une maladie et n'est pas le résultat d'une faiblesse, que seule la volonté pourrait corriger.   Lutter contre les préjugés  Aborder la question de l'obésité, c'est aussi s'arrêter sur le regard que porte la société sur le surpoids : d'un côté la face normative et restrictive, à quoi faut-il ressembler, quelle est l'image/la morphologie désirable ? Et de l'autre, l'incitation à la consommation, sucrée, salée, ultra-transformée. Prise en charge adaptée  Les causes et facteurs multiples du surpoids et de cet excès de masse grasse peuvent nécessiter une approche plurielle : conseils et réajustement nutritionnel, activité physique et à côté de ces changements en termes d'hygiène de vie, des traitements adaptés peuvent être recommandés, tels que la chirurgie bariatrique ou la prescription de médicaments, à l'instar des traitements injectables, appelés analogue du GLP1, recommandés en cas d'obésité chronique récidivante, chez les personnes présentant des complications du surpoids.  Avec : Pr Sébastien Czernichow, chef du service de Nutrition de l'Hôpital européen Georges Pompidou, et professeur en Nutrition à Paris Cité. Co-auteur de Arthrose arthrite - Je me soigne en mangeant et Arthrose, arthrite - Je me soigne en cuisinant aux éditions Solar. Co-coordonateur du réseau FORCE (F-CRIN).    Dr David Kodjo Kossi, endocrinologue diabétologue, nutritionniste au CHU Sylvanus Olympio à Lomé, au Togo. Président de l'Association Jeunes Intellect pour la Sécurité Alimentaire au Togo (JISATOGO). Directeur médical du Centre associatif d'éducation thérapeutique du diabète et de l'obésité, DIABEOBE.  Reportage de Raphaëlle Constant.   Programmation musicale :  ►  JAZZWRLD, MaWhoo, Thukutela, Gi-Ceejay – Uzizwa Kanjan  ► Pierre Akendengue - Awana W africa.

Selon l'OMS, l'obésité touche aujourd'hui plus d'un milliard de personnes dans le monde, et a entrainé 3,7 millions de décès dans le monde en 2024. Maladie chronique, l'obésité est également une maladie multifactorielle dont les causes peuvent être génétiques, environnementales, neurobiologiques... Comment expliquer l'augmentation exponentielle du nombre de personnes touchées par l'obésité ? Quelles peuvent être les conséquences sur la santé ? Quelles prises en charge existent ?  À l'occasion de la journée mondiale de lutte contre l'obésité, nous allons parler de la prise en charge de cette maladie à la fois complexe, liée à des facteurs multiples et variés. L'obésité implique de multiples défis pour les patients concernés : faire face aux conséquences potentiellement nombreuses de ce surpoids pour leur santé (pour le cœur, les articulations, en termes de santé respiratoire ou de fertilité) et surmonter le jugement des autres ainsi qu'un certain nombre de contrevérités au sujet de leur état. L'obésité est une maladie et n'est pas le résultat d'une faiblesse, que seule la volonté pourrait corriger.   Lutter contre les préjugés  Aborder la question de l'obésité, c'est aussi s'arrêter sur le regard que porte la société sur le surpoids : d'un côté la face normative et restrictive, à quoi faut-il ressembler, quelle est l'image/la morphologie désirable ? Et de l'autre, l'incitation à la consommation, sucrée, salée, ultra-transformée. Prise en charge adaptée  Les causes et facteurs multiples du surpoids et de cet excès de masse grasse peuvent nécessiter une approche plurielle : conseils et réajustement nutritionnel, activité physique et à côté de ces changements en termes d'hygiène de vie, des traitements adaptés peuvent être recommandés, tels que la chirurgie bariatrique ou la prescription de médicaments, à l'instar des traitements injectables, appelés analogue du GLP1, recommandés en cas d'obésité chronique récidivante, chez les personnes présentant des complications du surpoids.  Avec : Pr Sébastien Czernichow, chef du service de Nutrition de l'Hôpital européen Georges Pompidou, et professeur en Nutrition à Paris Cité. Co-auteur de Arthrose arthrite - Je me soigne en mangeant et Arthrose, arthrite - Je me soigne en cuisinant aux éditions Solar. Co-coordonateur du réseau FORCE (F-CRIN).    Dr David Kodjo Kossi, endocrinologue diabétologue, nutritionniste au CHU Sylvanus Olympio à Lomé, au Togo. Président de l'Association Jeunes Intellect pour la Sécurité Alimentaire au Togo (JISATOGO). Directeur médical du Centre associatif d'éducation thérapeutique du diabète et de l'obésité, DIABEOBE.  Reportage de Raphaëlle Constant.   Programmation musicale :  ►  JAZZWRLD, MaWhoo, Thukutela, Gi-Ceejay – Uzizwa Kanjan  ► Pierre Akendengue - Awana W africa.

Como funciona a conduta e quais os cuidados e interações medicamentosas podem acontecer durante a imunoterapia e demais tratamentos oncológicos? Aquele anti-inflamatório que a gente toma; as canetas emagrecedoras; antipsicóticos; corticóides, podem interferir diretamente em um tratamento oncológico? Neste episódio, dra. Veridiana Camargo, dra. Camilla Yamada, dr. Fabio Schutz, dr. Fabio Kater e dr. Marcelo Corassa levantam pontos de atenção relacionados a estas interações. Além de várias interações, nossos queridos experts citaram o vídeo do dr. Buzaid sobre agonistas de GLP1: https://www.mocbrasil.com/canais-moc/dicas/pub/dica-agonistas-do-receptor-de-glp-1 Sobre a dieta divina, se você ainda não ouviu - ou ouviu e se divertiu - vale relembrar este papo, com a participação da oncologista clínica dra. Carolina Alves da Costa Silva: https://www.mocbrasil.com/canais-moc/podcasts/pub/moc-cast-14-dieta-divina Você que é da área da saúde, já está cadastrado no site do MOC? Lá você tem acesso a vários conteúdos sobre oncologia atualizados pelos maiores experts do Brasil, além de episódios exclusivos deste podcast. O cadastro é gratuito e você fica por dentro dos vídeos citados nos episódios do MOC Cast: www.mocbrasil.com Siga o MOC também no Instagram: @mocbrasiloficial; e no LinkedIn: https://www.linkedin.com/company/mocbrasil/

Jay and Kay are back and confused about what exactly happened on this Industry season finale. We have our theories observations and hopes for the next season. Let us know what you thought of the season finale!Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Send a textToday we're joined by Dr Max Pemberton and Dr Courtney Raspin, authors of The Weight Loss Prescription, to unpack one of the most talked-about health shifts of our time: GLP-1 weight-loss medications.Are they a miracle? A medical breakthrough? Or a shortcut that risks creating new problems?In this conversation we explore what happens when you remove someone's primary coping mechanism, food, and why anxiety, low mood or even addiction can surface if the psychological work isn't done alongside the medical treatment. We tackle the tension between body positivity and health reality, the stigma and secrecy around using weight-loss medication, and why midlife with its hormonal shifts, muscle loss and bone health concerns changes the equation entirely.Most importantly, this is a compassionate, non-judgemental discussion. It's an honest look at what these medications can - and can't - do, and how to approach weight loss with both medical insight and psychological support.Whether you're on the medication, considering it or just interesting in the impact of GLP1's beyond weight loss, you're not going to want to miss this.For more information: https://theweightlossprescription.com/IBIZA RETREAT, May 2026: https://themidlifementors.com/retreats/ Support the showPlease remember, if you find the show helpful or it makes you laugh, motivates and inspires you - please do like, share and rate us. We don't run ads on the podcast or for the show, because we want to keep it as enjoyable for you to listen as possible. So if you can help us spread the word, we'd be incredibly grateful.For more information about The Midlife Mentors, click the below link:https://linktr.ee/themidlifementors.comTik Tok: @themidlifementorsIG: @midlifementors

In this episode, Jay Campbell shares his extensive expertise on hormonal optimization, peptides, fasting, and the future of biohacking to extend lifespan and enhance health. Discover actionable strategies to transform your body and mind, and learn about revolutionary tools that are redefining wellness. Key Topics The science behind GLP1 peptides and their role in ending obesity How therapeutic hormones and peptides support longevity and muscle preservation The impact of modern society's toxins on health and strategies to combat them The importance of metabolic flexibility, sleep, and mindset for longevity How peptides are naturally derived and their delivery systems (injections, patches, oral strips) The potential of emerging technologies like Klotho and Folistatin Jay's journey through hormone therapy, fasting experiments, and biohacking innovations Future trends: peptides becoming mainstream in gyms and clinics Practical tips for implementing fasting, lifestyle, and supplementation Timestamps 00:00 - Introduction: Unlocking human potential through health and longevity 02:42 - Jay's personal journey into hormone therapy and biohacking 07:17 - Using peptides for fat loss, muscle building, and longevity 12:22 - The story behind therapeutic hormones and their transformative effects 14:11 - Fasting as a tool: history, experimentation, and advanced programs 17:24 - Steroids, peptides, and their impact on physical and mental health 22:18 - How peptides target healing, cognition, and metabolic regulation 28:16 - Delivery systems: injections, patches, oral strips, and future innovations 33:04 - The rise of peptides in the biohacking industry and future potential 39:30 - Cost considerations for peptide regimens now and in the future 43:17 - Society's toxins and the importance of quality food sourcing 46:01 - Foundations for longevity: diet, sleep, exercise, and mindset 48:46 - The vision of a future where health optimization is accessible worldwide 50:15 - Age is just a number: inspiring stories of aging with strength and vitality 53:21 - Connecting with Jay: Resources, books, and how to get started Resources & Links Metabolic Awakening with GLP1 Peptides on Amazon  Jay Campbell's Official Website BioLongevity Labs Connect with Jay Campbell X (Twitter) Instagram Email/Contact Thank you for tuning in! Don't forget to check out Jay's books and resources to kickstart your journey toward optimal health and longevity. Disclaimer: This podcast is for educational and personal development purposes only. The views shared are based on personal experience and are not intended to replace professional medical, psychological, or legal advice. Please seek a qualified professional for guidance specific to your situation.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What if the reason you’re not healing isn’t that you need another diagnosis? 0:08 It’s that your cells aren’t receiving the right signals. Because the body doesn’t run on diagnosis, it runs on 0:16 communication. And peptides are one of the most powerful, most misunderstood 0:21 tools we have for cellular signaling, immune balance, tissue repair, gut 0:27 lining support, metabolic control, brain signaling, sleep cycles, and even sexual 0:35 wellness. Today, I’m going to do what most people won’t. Define peptides in 0:41 plain English for you. break them into categories by what they’re best at and 0:47 tell you which ones are FDA approved on the list and which ones are commonly 0:53 used off label or investigational with the evidence that actually says these 1:00 work. This is going to be a powerful episode and if you’ve ever felt like you’re hearing hype without clarity, 1:07 this one’s for you. So, as usual, grab your cup of coffee or tea and settle in 1:13 as we talk about peptides that can fit into your healing journey. We’re going 1:19 to have a short word from our sponsor. You know, we got to do that. That’s how we stay on the air here. So, we will be 1:26 right back after this. Did you know sweating can literally heal your cells? 1:32I nfrared saunas don’t just relax you. They detox your body, balance hormones, 1:37 and boost mitochondrial energy. I’m obsessed with my health tech sauna. And 1:42 right now, you can save $500 with my code at healthtechalth.com/drmuthqen25. 1:54 All right, here we go, guys. I am excited to dive into peptides with you. 2:00 So understanding peptides is foundational, right? And I’ve been 2:06 studying peptides now for about nine years. Um, and I find that they are 2:13 incredible. Um, so I want to break down for you what peptides actually are, what 2:19 they do, and some of the top peptides that are available today, and how they 2:25 can be utilized. Because I think it’s really important. And I think it’s it’s there’s a lot of confusion out there about what these things actually are and 2:32 are they safe? Are they not? When do we use them? What’s the science behind them? So, we’re going to dive in and 2:38 we’re going to talk about all things peptides. So, let’s get ready here. Here we go. So, peptides are short chains of 2:45 amino acids and they typically range anywhere from 2 to 50 amino acids and 2:51 they’re linked by peptide bonds. So think of them as the superglue that holds the amino acids together. They sit 2:58 between the amino acids and they are full proteins in terms of their size and 3:04 their complex structure. And what makes peptides particularly interesting in 3:10 medicine is their role as signaling molecules. They’re essentially the 3:15 body’s text messages carrying specific instructions to cells and tissues. And 3:21 unlike our proteins which often serve as structural roles or act as enzymes, 3:28 peptides typically function as hormones, neurotransmitters and growth factors and 3:33 they bind to specific receptors on the cell’s surfaces or within the cells and 3:39 they trigger this effect. It’s like a cascade effect of a biochemical reaction 3:45 that ultimately changes the cellular behavior. So basically, it’s changing 3:50 the way the body’s cell structure acts. And this is why peptides can be so 3:56 incredibly powerful and therapeutic when you introduce the right peptide signal. 4:02 Now, you could theoretically redirect cellular processes toward healing, 4:07 towards metabolism, immune balance, tissue repair. Any of those things can 4:14 be manipulated to do a certain thing once we add the peptide. The challenge 4:19 in peptide medicine though lies in distinguishing between those peptides that have been rigorously studied, 4:26 proven safe and effective and approved by regulatory bodies like the FDA versus 4:31 those that exist in what we call the gray zone of a promising clinical data. 4:36 But they really lack human validation so far. And this distinction is critical because the presence of a plausible 4:43 mechanism does not guarantee safety or efficacy in living humans. So, this is 4:50 really important and we’re going to dive in and look at some of the research on all of these different peptides that are 4:56 available and I’m excited to say there’s some amazing peptides being studied right now that unfortunately are not 5:01 available. But I can’t wait to see them hit the market for us because it is going to be a gamecher as far as health 5:09 and longevity. So there is a quality control issue and there is a hidden 5:14 variable in peptide medicine with this and it’s one of the most underappreciated aspects of peptide 5:21 therapy particularly for non-FDA approved peptides. It’s quality control. 5:26 When we discuss pharmaceutical medicines, we take for granted that the pill contains what the label says. Not 5:32 always true depending on where it comes from. You guys, if you’ve heard my episodes before talk about how many of our medications are made in China and 5:41 have been contaminated with other things, you will realize that that is not always true. So, just because it has 5:48 the FDA stamp of approval on the medication, it still does not necessarily mean it’s safe and we still 5:54 need to do our homework on it. So, sorry for digressing on you guys, but you know, when we get a medication, we we 6:00 think that what the amount says is what is there, doesn’t have contaminants, it’s manufactured with good 6:06 manufacturing practices. You’ll see that listed as GMP on the bottle, and it’s been stored properly, it’s been 6:12 maintained stable, and with research peptides and compounded formulations, 6:17 none of this can be assumed. So, I will share a story with you. There was a gentleman that was purchasing these 6:24 peptides online from a research facility and um did not know that they were 6:30 coming from China and he was ordering a particular growth hormone peptide and 6:35 after a little while he had he had done fine for the few first few bottles. After a little while he started having 6:42 some complications. He started getting really irritable and angry and ragy and 6:47 he didn’t quite know what was going on. And so he decided to go get some testing done. He had some blood testing done and 6:53 his testosterone level was over 5,000. So for those of you who know what testosterone level should be for a guy, 7:00 they really shouldn’t be any higher than about 1,00200 would be absolute max that we’d want to see. Now he was taking 7:06 testosterone but not to that degree. And prior to adding this peptide, his 7:12 testosterone was very stable. What they ended up finding out was the peptide that he was getting, whoever was 7:18 manufacturing it added testosterone to the peptide. They felt like if if it had growth hormone, that was great, but if 7:25 it had growth hormone and tes testosterone, all the better. And he didn’t know that. And this is the 7:31 problem that we can have with peptides if you don’t source them properly. if you’re not working with somebody that 7:37 knows how to source them and can prove that they are what they say they are. Um, I’m sure there’s a whole bunch of 7:42 studies out there too of people getting these peptides and paying hundreds of thousands of dollars for them over their 7:48 lifetime and finding out they were nothing more than just sterile water. So, you really do need to be careful 7:53 with your quality control. Now, this kind of leads us right into the next topic that we’re going to talk about and that’s the manufacturing question, 8:00 right? The FDA approved peptides are manufactured in facilities subject to 8:05 the FDA inspection rules following our GMP regulations and these facilities 8:11 must validate their manufacturing process, demonstrate consistency batch to batch, test for purity and potency. 8:18 They need to test for bacterial endotoxins and sterility and they need to maintain detailed records. So, when a 8:25 pharmaceutical company submits a drug application, the FDA inspects the manufacturing facility as part of the 8:32 approval process. If you’re getting peptides from a different country, none of that is happening. And there are some 8:38 ways for us to determine if that is what you’re getting. Typically, the rule of thumb is if your peptides are coming 8:44 with a different colored top, every one of them has a different colored top. Those are typically being sourced out of 8:49 China. I wouldn’t say that’s 100% but that’s kind of the rule of thumb that people follow. So compoundingies these 8:56 are thearmacies that make our bio identical hormones. They can make medications in any dose or strength or 9:02 route. There are thousands of them in every not that not in every state but 9:08 there are thousands of them around the country right now. So these compoundingies are registered as 503A 9:15 facilities. They do traditional compounding for individual prescriptions, right? Like they can make 9:20 thyroid, they can make LDN, they can make estrogen. You can also have a 503b 9:27 facility, which is an outsourcing facility. And these companies produce larger batches of products. They’re they 9:34 have some oversight, but they’re less stringent than for FDA approved 9:40 manufacturers. And state boards of pharmacy regulate a 503A pharmacy. And 9:45 the FDA can inspect the 503b facility, but doesn’t preapprove any of their 9:52 compounding products. So, they can inspect it, but they don’t approve them. So, research chemicals and these 9:58 suppliers operate essentially with no oversight. They explicitly market products for research use only, not for 10:06 human consumption to avoid FDA regulation. If they put that on their 10:12 product, they don’t have to comply to what the FDA is saying. And there is no required manufacturing strategies or 10:19 standards, no required testing, no required sterility assurance, and no enforcement mechanisms if products are 10:26 mislabeled or contaminated. So basically, they don’t have the liability, but that doesn’t mean that 10:31 all of them are badies or bad suppliers. It just means they don’t have to comply 10:37 to the FDA rules. Now, there are many of these companies that I’ve seen and I’ve talked to that do do a lot of this. They 10:44 do test their product for sterility. They do test their product to make sure it is what it says it is. They don’t 10:51 have to, but they do. So, if you’re going to decide to use a company that 10:56 has research only, not for human consumption, at least ask for their 11:02 proof of testing so that you know that the product you’re getting is what it says it is and that it’s clean. Because 11:08 this is where we run into the problem is in purity. So in purity peptide 11:13 synthesis can produce not just the targeted peptide but also related 11:19 peptides with deletions, substitutions, truncations or truncations of amino 11:25 acids. Sorry. And this high performance liquid we call it uh chromatography can 11:30 separate these related impurities and quality and quantify the actual target 11:35 of the peptide content. So a certificate of analysis is what you want to ask these companies for. This shows the HPLC 11:44 the testing mechanism with greater than 95% or ideally 98% purity which 11:51 indicates a higher quality product. So this certificate of analysis can be fabricated may not represent the 11:57 specific batch being sold. It happens. We need to know not everybody is honest. Not everybody, you know, does what they 12:03 say and it does what’s right. But at least you at least they’re giving you something and you have some security. 12:10 and then choose a company that was referred to by someone else that has done some homework as well. In in 12:16 commercial research, there’s independent testing and they research peptides and this has been really shocking 12:23 variability that they’ve seen. Some products contain 50% or less of the 12:29 claimed peptide and some contained primarily degradation of the product or manufacturing impurities and some 12:36 contained bacterial endotoxins at levels that could cause fever and systemic 12:42 inflammation if it was truly injected. And I would also worry with some of those problems, you know, depending on 12:48 what impurity or bacterial endotoxin was there. If you’re using a product to boost your immune system and your immune 12:54 system is already compromised, these bacterial endotoxins can actually make you sicker instead of what you want it 13:02 to do, which is making you better. So, sterility is always an issue with anything that is manufactured, 13:08 especially things that we’re doing as an injection. Peptides are intended for injection. They must be sterile. They 13:16 must be kept safe. And pharmaceutical manufacturers conduct this sterility testing on every batch. 13:22 Compoundingarmacies should conduct sterility testing particularly for high-risisk compounded 13:28 sterile preparations and research chemical suppliers may or may not conduct any testing. So injecting 13:35 non-sterile material can cause local infections, abscesses at the injection 13:41 site and or if the bacteria enters the bloodstream could potentially be 13:46 life-threatening and you could have sepsis. Now, excuse me. We saw this 13:52 happen in a compounding pharmacy uh gosh, it’s probably been 10 years ago 13:57 now, I think. um they unfortunately had a strep uh contamination in their 14:03 product and they weren’t testing it. It was a large compounding pharmacy out of Florida and they were making products 14:08 that were being injected into the joints and um these people got very very sick 14:14 and some of them died and um some of them got very very injured by this uh 14:21 complication that happened. So it’s not like this doesn’t happen. It does, but it doesn’t happen often. And that’s what 14:28 we have to know about. And so, when we’re talking with you guys about storage and stability, it’s really 14:34 important to make sure you maintain your peptides well. So, many peptides are unstable at room temperature. They 14:41 require refrigeration or freezing. We tell everyone to make sure you’re refrigerating your peptides. That way, 14:48 there’s no question about it. when it stays cold um it prevents or slows down 14:54 the process of uh bacteria growing in it. So some of these peptides actually 14:59 degrade very rapidly in the solution and they must be reconstituted immediately before use and reconstitution of the 15:07 peptides really has limited stability often just days to weeks not months. So 15:13 improper storage, temperature, um changes during shipping or prolonged 15:19 storage of a reconstituted product can lead to degradation into inactivity or 15:25 potentially even a harmful breakdown of the product itself. So if you have a product that’s been sitting in your 15:30 refrigerator for a month or two months or 3 months or 6 months, just throw it away. It’s not going to be any good. 15:37 you’re not going to actually get the peptide and the uh potency that you’re looking for anyway out of it and the 15:44 potential of you introducing an endotoxin, a bacterial endotoxin is quite high at that point. So you just 15:50 really don’t want to take the risk, excuse me. So what practitioners, what 15:56 should we do and what should patients do? Well, for any peptide therapy, we 16:03 want to source our verification. know where the peptide product comes from. Is 16:08 it an FDA approved product? Is it a 503b compounding? A research chemical 16:14 supplier? Is there a certificate of analysis? Request and review this COA. 16:20 And you want it to show purity greater than 95% but ideally greater than 98%. 16:27 You want that identity be identity to be confirmed by mass spectromedy. Uh 16:33 sterility testing should be done. Bacterial endotoxin testing should be done. Batch number matching of the 16:39 product that you received should be done. Proper storage. You want to know that this has been refrigerated or 16:46 frozen as directed once it’s been mixed. Look at the expiration dates for reconstituting your peptides. Track that 16:53 reconstitution date and discarded accordingly like we just talked about. Monitor for your adverse effects. Even 17:01 with the perfect quality control, monitoring for adverse effects is essential with questionable quality and 17:08 vigilance is really critical here. I know it’s frustrating for a lot of patients when they have to get several 17:15 bottles and they only last a week or two. right here, you guys. This is why 17:21 they only last a short period of time because once they’re mixed, they start 17:26 to degrade and they won’t be good and you won’t get the benefit from it. So, 17:31 it’s really important with these research peptides specifically, practitioners should recognize that all 17:38 recommending products without quality assurance violates the fundamental medical principle of first do no harm. 17:45 If a patient is determined to use research peptides despite counseling, providing guidance on quality 17:52 verification, requesting those COAs, using pharmaceutical grade sources when available, proper testing, this all 17:59 reduces harm, but doesn’t constitute necessarily that recommendation. Now, 18:06 that being said, today it’s very difficult to find peptides by the compoundingies because of what the FDA 18:13 has done. So most of the peptides that are available to us have been labeled 18:18 not for human consumption, not because they’re not good products, but because 18:25 of what the FDA did. And this is how these companies have been able to 18:31 continue to provide peptides to the medical community. And if you know you 18:36 have a good company, then you’re, you know, you’re still taking the risk, right? But at the end of the day, the 18:42 reason they’re doing that is to protect themselves from the FDA, from liability. Um, so just kind of know that there is 18:50 some talk in the community with um Bobby Kennedy that this is going to change and 18:55 they are going to bring peptides back to the compounding pharmacies. Now, we don’t know which ones they’re going to 19:01 bring back. Uh, will it be all of them? Will it just be some of them? What’s going to happen here? Um, is it going to 19:07 go to the pharmaceutical companies like our GLP1s did? We don’t know what that’s going to look like quite yet. Um, but it 19:14 is coming and that is positive news. So, let’s talk now about FDA approved 19:21 peptide medications. So, this is the metabolic revolution, right? GLP1 19:28 and our dual increeting agonists. This is an exciting time. GLP-1s are amazing. 19:35 Um, a lot of people are skeptical, a lot of people love them, a lot of people hate them. Whichever side of the fence 19:42 that you’re on, I understand. But I want to talk about the science of it today 19:48 and what it actually means for people. So, the story of GLP1 glucagon like 19:54 peptide one represents one of the most significant advances in metabolic 19:59 medicine in the past several decades. GLP-1 is an accretin hormone. It’s 20:05 gutder derived peptide that potentiates insulin secretion in response to food 20:11 intake. And the body naturally produces GLP-1 in the intestinal L cells, but it 20:17 rapidly degraded by the enzyme DPP4 giving it a halflife of only about 2 20:24 minutes. So this rapid breakdown made in therapeutically impractical until 20:31 research was developed and modified the analoges that resist the enzyme degradation. So for those people who 20:39 never feel full when they’re eating, never feel satisfied when they’re done, this is because their body is either not 20:46 producing enough GLP1 or it’s not getting the signal right. And this is a 20:51 leptin issue. This is an insulin issue. It’s a GLP-1 issue. It’s a complicated 20:56 issue. This is not anything that the person is doing wrong. It’s what is happening to their body. And so GLP1s 21:03 have really revolutionized this. So one particular GLP-1 that we have is 21:09 semiglutide. And this GLP-1 agonist is what changed everything in the world of 21:16 metabolic medicine. Semiglutide is marketed as ompic for type 2 diabetes 21:23 and it’s marketed as WGOI for chronic weight management. It is a modified 21:29 GLP-1 analog with 95 or sorry 94% amino acid sequence uh homology to human 21:37 GLP-1. So it means that it’s it’s just like our own GLP-1 that we make. This 21:42 modification includes specific amino acid substitutions and the addition of C18 21:50 a fatty acid chain which allows the peptide to bind to albumin. Now this 21:56 albumin binding dramatically extends the half-life to approximately one week 22:01 enabling one weekly dosing which is a major advantage over the earlier GLP-1 22:07 agonists that require daily or twice daily injections. The mechanism by which 22:13 semiglutide works is multiaceted. At the pancreatin level, it binds to GLP-1 22:20 receptors on the pancreatic beta cells enhancing glucose depending sorry 22:27 enhancing glucose dependent insulin secretion. This glucose dependency is 22:33 crucial. It means the peptide only stimulates insulin release when blood glucose is elevated. This dramatically 22:41 reduces the hypoglycemic risk compared to insulin or even uh sulfuras. 22:47 Simultaneously semiglutide suppresses glucagon secretion from pancreatic alpha 22:53 cells further improving glycemic control. This is really amazing because 23:00 over the years when we’ve used insulin, which is also a peptide by the way, you 23:05 had to dose it just right because if you didn’t, you would produce so much insulin that it would crash the blood 23:12 sugar and then somebody would have too low of a blood sugar. They’d be hypoglycemic and they’d have to eat more 23:18 sugar and then they’d have to modify the insulin again and the person would be going up and down, up and down, up and 23:24 down all day long. And that created a lot of problems for people and so this 23:30 helps to stabilize that so it is not such an intense change. Now in the GI 23:36 tract semiglutide delays the gastric emptying particularly pronounced during 23:41 the initial weeks of therapy. This slowing of the gastric emptying contributes to the sensation of being 23:48 full and early satiety that patients often describe. However, this effect 23:54 tends to attend to weight over time as the body adapts through the appetite 24:00 suppressing effects generally persist through central mechanisms. So, when we 24:05 talk about what is actually happening, we’re slowing that digestive process down. That’s why people aren’t so 24:11 hungry. It’s why they’re not eating so much. This is why people can develop constipation with these products because 24:17 it’s slowing the body’s digestive tract down. Now some people will call this 24:22 gastroparesis. Um gastroparesis is actually different. 24:28 It is when we lose control over what’s happening in the in the colon like the 24:34 nerves and things like that just stop working. I have never seen that with the GLP1s that we prescribe in micro doing. 24:42 um it’s been documented. It can happen, but again it a lot of it is dosing and a 24:48 lot of it is staying on top of your client and what’s happening and what’s going on and what you’re doing and making sure that they do have good 24:54 motility still. So a lot of these things can be mitigated if you have problems 24:59 with them. Now one of the most profound effects of semiglutide occur in the 25:05 central nervous system. GLP-1 receptors are widely distributed in the brain 25:10 particularly in the hypothalamus and the brain stem area where we are involved in 25:15 appetite regulation. So when when wilding and colleagues published their 25:20 landmark step one trial in the New England Journal of Medicine in 2021, 25:25 they demonstrated that participants receiving 2.4 4 milligrams of semiglutide weekly achieved an average 25:32 weight loss of 14.9% of their body weight over 68 weeks. Now, I want you 25:39 guys to really understand this. We’re talking roughly 15% body weight loss 25:45 over a year, longer than a year. 52 weeks is a year, right? This is 68 25:50 weeks. So, it took longer for them to lose. We’re not talking about giving 25:55 somebody a dose to lose 15% of their body mass in a month or two. That that 26:01 is not healthy for any of us. That is not what we’re talking about doing here. Now, they compared this to placebo and 26:08 the placebo was only 2.4%. So, that is a significant difference. 26:14 And even beyond the numbers, patients reported something very qualitatively different, a reduction in what’s now 26:21 called food noise. Everybody knows what food noise is. We’ve talked about this long before GLP1. It’s that craving. 26:28 It’s that part of your brain that just keeps thinking about I want to eat something. You know, that was actually 26:34 reduced and they didn’t expect to see that happen. Now, this refers to the constant mental preoccupation with food, 26:42 the intrusive thoughts about eating, the difficulty in feeling satisfied. Semi-glutide appears to appears to 26:49 modulate reward pathways in the misolyic system reducing hedonic eating and food 26:57 cravings. Now there are also great cardiovascular effects of semiglutide 27:02 that extend beyond weight loss. Uh the sustained six and select trials 27:07 demonstrated significant reductions in major adverse cardiovascular events uh 27:14 mace in high-risisk populations. The select trial published in 2023 showed 27:20 that semiglutide reduced cardiovascular death, non-fatal myioardial inffection 27:25 and non-fatal stroke by 20% in adults with overweight or obesity and 27:31 established cardiovascular disease but without diabetes. So this suggests that 27:37 mechanisms beyond glucose control and weight loss possibly including 27:42 anti-inflammatory effects, improvements in endothelial function and favorable 27:47 changes to lipid profiles. Now I will tell you the clients that I work with that are on GLP1, 27:53 they will tell you that their inflammation has been significantly reduced. We are also seeing really 28:00 amazing results in lipid profiles. um part of its weight loss, but there is a 28:06 component to this that is lowering the triglyceride levels because it’s related to sugar and how the body’s processing 28:11 it. And we’re seeing better profiles, less need for statins as a result of 28:17 that. If if you want to listen to my episode on statins, I have one on that. Uh they are not my favorite medication. 28:24 I think it’s overprescribed and overused um and not really affecting or 28:29 addressing the problem. So these things can really be helpful. There’s also some 28:34 uh ramblings going on with GLP-1s saying that they may be able to help with 28:40 addiction in the future because of where they’re finding it affecting the brain and how it affects the food noise and 28:47 the cravings that we have for food and the addiction for food. Could it potentially help with other addictions 28:53 down the road? We’ll have to wait and see on that one. So semiglutide’s FDA prescribing information also includes a 29:00 box uh boxed warning about thyroid sea cell tumors. So in rodent studies 29:06 semiglutide caused dose dependent and treatment duration dependent sea cell 29:12 tumors at clinically relevant exposures. So while it’s unknown whether or not 29:17 semiglutide causes uh thyroid cancer tumors in humans and the rodent thyroid biology 29:26 differs significantly from humans, the drug is contraindicated in patients with a personal or family history of 29:33 medillary thyroid carcinoma or in patients with multiple endocrine neopl neoplasia syndrome type two. it is 29:42 uh contraindicated for safety effects with that. Um I have seen endocrinologists okay GLP1s to be used 29:50 in patients who’ve had other forms of thyroid cancer just not the meillary 29:55 thyroid cancer. So there is possibility there. Now the most common side effects 30:00 are gastrointestinal. It’s nausea affects about 20 to 44% of patients 30:06 depending on the formulation with diarrhea, vomiting, constipation, abdominal pain, and also frequently 30:13 reported in clinical trials. I see this in my clinic, too, especially dose dependent. Um, and it happens early on 30:20 when you’re first starting the medication, but seems to settle out over time. The one that I would add to this 30:26 that I don’t think they have on here is an increase in acid reflux. We also see that quite often uh especially in people 30:33 who suffer with acid reflux to begin with. Now these effects are typically most 30:40 pronounced during the escalation and they like I said often improve over time 30:45 but more serious but less common adverse effects include acute pancreatitis. 30:51 The medication needs to be discontinued immediately if this is confirmed. You can see some diabetic retinopathy 30:57 complications in patients with pre-existing retinopathy and acute kidney injury. Um, this usually happens 31:05 secondarily to dehydration from the GI effects. There are some gallbladder disease um that can occur and people who 31:13 have a sensitive gallbladder will describe uh discomfort with that. I’ve 31:18 even seen some people who’ve had their gallbladder out on GLP1s at the higher doses complain of similar pain that they 31:25 used to have when their gallbladder was in. So, really important to just kind of monitor these symptoms and work closely 31:32 with somebody that understands them and can be on top of them quite quickly if this happens. Excuse me. From an 31:39 integrative medicine perspective, semiglutide really represents a powerful tool, but it’s not a standalone 31:46 solution. Remember, the medication addresses one aspect of the metabolic dysfunction, the signaling systems 31:53 controlling appetite and glucose homeostasis, but it doesn’t address the root cause that led to the metabolic 32:00 disease in the first place. Patients who rely solely on the medication without addressing the ultrarocessed food 32:07 consumption, the ccadian disruptions, the chronic stress, the sleep apnea, or 32:12 underlying hormonal imbalances often experience weight regain when the medication is discontinued. 32:20 The drug is also not a substitute for addressing the emotional and psychological drivers of eating 32:26 behavior, including the unresolved trauma that may manifest as emotional eating. I think this is really important 32:33 because we don’t address the trauma issue enough with clients and we need to 32:38 be looking at that. There is a huge trauma effect out there these days that is I don’t want to say leading to or 32:45 causing but it is definitely contributing to chronic illness and it’s not being talked about enough. So we 32:52 really need to be talking about this and addressing this trauma aspect. Now the next GLP that one that I want to talk 32:59 about is trespathide. This is a dual agonist. It takes center stage. It is my 33:05 favorite GLP one. Trisepatide is marketed as Mangjaro for type 2 diabetes 33:11 and Zepbound for chronic weight management and it represents the next 33:16 evolution in increantbased therapy. This is a dual agonist a 39 amino acid 33:23 synthetic peptide structurally based on the human glucose dependent insulin tropic peptide so GIP sequence but 33:31 modified to activate both the GIP receptors and the GLP1 receptors. So the 33:37 addition of the GI GIP agonism to the GLP1 agonism appears to create this 33:46 synergistic effect that goes beyond simply adding the two mechanisms together. So the GIP like GLP-1 is an 33:55 increant hormone secreted by what is called the K cells in response to nutrient intake. It enhances glucose 34:02 dependent insulin secretion but it also effects on atapost tissue metabolism 34:09 potentially improving the insulin sensitivity in fat cells and influencing 34:14 how the body stores and metabolizes fat. So some research suggests that GIP may 34:20 also have effects on energy expenditure though this remains an area of 34:26 investigation. So basically what we’re saying is this drug may actually help 34:32 people who are insulin resistant or insulin sensitive, not just somebody who 34:38 has problems with glucose control. So, this is super exciting because it opens 34:43 up the door for all of these people for decades that we’ve been trying to manage with insulin resistance and trying to 34:50 prevent diabetes and honestly most of the time have been unsuccessful 34:56 unless you can keep your diet at 50 grams of carbs or less a day, which is extremely difficult. Um, and take some 35:04 supplements that may or may not work and or take some metformin that may or may not help. this drug actually really 35:11opens that up and helps in that capacity. So there was a clinical trial 35:17 called the surmount clinical trial which demonstrated that trespathide produces 35:22 even more substantial weight loss than semiglutide. In the surerount one trial published by uh J tree I might have said 35:31 that wrong. I apologize if I slaughtered your name and colleagues in the New York England Journal of Medicine in 2022. 35:38 Participants receiving the highest dose of trespide, which is 15 milligrams, achieved an average weight loss of 20.9% 35:47 of their body weight over 72 weeks, compared to 3.1% with placebo. This 35:54 level of weight loss approaches what’s typically only seen in beriatric surgery. So, this is amazing because if 36:02 this medication works and we don’t have to do beriatric surgery, stomach stapling basically, um, oh my gosh, it’s 36:11 amazing. There are so many complications and risks that go with stomach stapling and the different procedures that they 36:17 do these days. People don’t absorb their nutrients properly. They have to do liquid nutrients. It’s very complicated. 36:24 It’s very challenging. Many of these people gain their weight back. Um, and 36:30 this procedure is not fun to go through. So, if we could change that and change 36:35 the lives of people who’ve really been struggling, it is amazing. And I will tell you that I have seen this work. I 36:42 have seen people lose 100 150 pounds on these medications over a year or two 36:50 period of time. It is definitely slower than beriatric surgery on some standpoints, but that is okay. You don’t 36:56 want that rapid weight loss. It’s not good for you. It’s not healthy for you. It doesn’t look well. You know, we want 37:03 to do this safely and effectively in the best way that we can possibly do that for you. Now, the adverse effect profile 37:10 is similar to semiglutide. It’s dominated by gastrointestinal effects. 37:15 Nausea, diarrhea, decreased appetite, vomiting, constipation. These were all commonly reported in the surmount 37:22 trials. And like semiglutide, tricepide carries a blackbox warning regarding the 37:27 thyroid sea cell tumors based on the rodent data and it shares the same contra indications in patients with a 37:34 family history of thyroid cancer and men too. So the mechanism behind why 37:40 tepatide often produces more substantial weight loss than GLP-1. The agonism 37:45 alone remains under investigation, but it may relate to the complimentary effects on the different aspects of 37:51 energy homeostasis or to GIP’s effects on atapost tissue and potentially on 37:58 central central nervous system pathways that GLP1 alone doesn’t fully address. 38:03 Now patients often report even more profound reductions in food noise with tricepide compared to GLP1 and uh sorry 38:12 GLP1 the agonists through this is anecdotal and hasn’t been regularly 38:17 quantified in quality studies. So I’ve done both uh personally and in my 38:22 practice. I really like trespide better than semiglutide. For me I had too many side effects with semiglutide. uh I had 38:30 less side effects with trespathide. I also plateaued on semiglutide which I 38:35 didn’t really care for. And with Tresepide, I haven’t plateaued and I’ve been able 38:42 to lose about 25 pounds in um a year and a half and I’ve been able to maintain 38:49 that. Um and I continued to use it because I do have a strong family history of cardiovascular disease. And 38:56 if this could help me so that I don’t follow my family lineage with cardiovascular disease, I am all for 39:03 trying to do that. I’ve watched too many of my family members suffer from this. I’ve lost my dad at a very young age. I 39:09 lost my grandfather at a young age to it. All of their brothers to this. And I don’t want to be that same person. So 39:16 that is why I chose to do that. And I think it’s really important for us to take a look at that and understand that. 39:24 Now, I know this has been a really long podcast and I don’t typically do podcasts this long. I have a whole host 39:31 of information on additional peptides. So, I’m going to break this up for you 39:36 guys and I’m going to do another episode and we’re going to pick up where we left off here with these peptides so that we 39:43 can actually start to dive into different peptides as well. So, check 39:48 out my next podcast show when we’re going to dive into the peptides that 39:54 talk about sexual wellness, immune function, and all the other cool things 39:59 that we can do with peptides. So until then, remember to like, share, and 40:04 subscribe. It really helps us get out to other people and share our information, 40:10 and join us for our next episode as we continue the talk about peptides. 40:15 Welcome to Let’s Talk Wellness Now, where we bring expert insights directly to you. Please note that the views and 40:21 information shared by our guests are their own and do not necessarily reflect those of Let’s Talk Wellness Now, its 40:28 management, or our partners. Each affiliate, sponsor, and partner is an 40:34 independent entity with its own perspectives. Today’s content is provided forformational and educational 40:40 purposes only and should not be considered specific advice, whether financial, medical, or legal. While we 40:48 strive to present accurate and useful information, we cannot guarantee its completeness or relevance to your unique 40:56 circumstances. We encourage you to consult with a qualified professional to address your 41:01 individual needs. Your use of information from this broadcast is entirely at your own risk. By continuing 41:08 to listen, you agree to indemnify and hold Let’s Talk Wellness Now and its 41:14 associates harmless from any claims or damages arising from the use of this 41:20 content. We may update this disclaimer at any time and changes will take effect 41:26 immediately upon posting or broadcast. Thank you for tuning in. We hope you 41:31 find this episode both insightful and thought-provoking. Listener discretion 41:36 is advised.The post Episode 256 – How Peptides Work, Benefits, and FDA-Approved vs Off-Label Use Explained first appeared on Let's Talk Wellness Now.

Raven is back as we have our last chat about Lucy and dem. Tell Me Lies was raggedy for making this their last episode ever but boy was it a good one. Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFollow Raven: https://www.instagram.com/mainlyraven/?hl=enListen to Bitch Is Better:https://podcasts.apple.com/us/podcast/bitch-is-better/id1496516498FOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

THE TITLE SAYS IT ALL. OH AND KAYA AND KENDRICK TALK PART 2 OF THE RHOP REUNION!FOLLOW KENDRICK: https://www.instagram.com/withkendricktucker/?hl=enLISTEN TO HIS PODCAST: https://podcasts.apple.com/gm/podcast/i-ken-not-with-kendrick-tucker/id1525311067Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblacKFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Send a textMost people think body image is about weight.It's not.Body image is about the story you learned about yourself — often long before you understood what calories or cellulite even were.In this episode, we explore:What body image actually is (and why it's not just about the mirror)How childhood experiences shape the way you see yourselfWhy we often perceive our bodies inaccuratelyThe emotional triggers that intensify body dissatisfactionWhy self-criticism doesn't create sustainable weight lossWhy even people who lose weight — including those using GLP-1 medications — can still feel deeply unhappy in their bodiesIf you've ever believed:“I'll feel better about myself when I'm thinner,” this episode gently challenges that idea.This is not about forced body positivity.It's about understanding the psychology behind body image — and learning how to stop letting it quietly run your life.Because your life is happening now.Not ten kilos from now.Thanks for listening, I hope this episode will be helpful.Philippe

In this episode of the Optimal Body Podcast, hosts Doc Jen and Doctor Dom, both Doctors of Physical Therapy, welcome Jennifer Gularson, a leading expert in women's midlife health and functional medicine. Together, they discuss hormone replacement therapy, GLP-1 medications, and the challenges women face during perimenopause and menopause. Jennifer emphasizes individualized, science-based care, shares practical tips for symptom management, and highlights the importance of holistic approaches—including lifestyle changes and patient advocacy—to optimize women's health and longevity. The episode offers compassionate guidance and actionable insights for navigating hormonal changes, hormone replacement therapy and improving overall well-being. Needed Discount: Jen trusted Needed Supplements for fertility, pregnancy, and beyond! Support men and women's health with vitamins, Omega-3, and more. Used by 6,000+ pros. Use code OPTIMAL for 20% off at checkout! Just Press Play Discount! Have you been putting starting your new exercise or movement routine on pause for too long?! Come join us because now is the time to "Just Press Play!" Take the toughest step and just start one video. I promise you'll feel the difference in your body and come back for more! Listeners get a bonus discount with code OPTIMAL at checkout. Dr Gularson's Resources: Dr Gularson on IG Dr Gularson's Website We Think You'll Love: Free Week of Jen Health Jen's Instagram Dom's Instagram YouTube Channel FREE Postpartum Guide! For full show notes and resources visit: https://jen.health/podcast/449 What You'll Learn from Dr Gularson: 04:55 Jennifer shares her career path, early experiences with menopause care, and transition into functional medicine and hormone replacement therapy. 09:08 Discussion of common complaints from women experiencing perimenopause and menopause, and the importance of validation. 11:23 Emphasis on the need for integrated, team-based care and listening... Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Timestamps00:06 - Live stream with Liz discussing her new stylish headphones.01:56 - YouTube's changing algorithms impact subscriber counts and content quality.05:49 - Quick diagnosis leads to unnecessary statin prescription without proper testing.07:52 - Pharmaceutical trust can lead to misunderstandings about health issues.11:31 - Discussion on creating alternative food resembling traditional dishes.13:35 - Struggling with diet consistency requires reliable fallback options.17:18 - Discussion on dragon fruit and its carbohydrate content in a carnivore diet.19:09 - Carnivore diet may reduce inflammation, but supplements can still be beneficial for some individuals.22:34 - Patient experiences unusual reactions related to amoxicillin and hearing loss.24:13 - Discussion on the complexities of steroid and antibiotic usage in medical treatment.27:44 - Recognizing the importance of mistakes for personal and professional growth.29:30 - Learning from dietary mistakes can improve future choices.32:34 - Carnivore diet simplifies meal preparation and reduces food-related stress.34:18 - Discussion on the impact of GLP1 drugs and faith in pharmaceutical practices.37:49 - Study lacks proof on patient leaflet reading impacting drug side effect claims.39:49 - Public awareness is challenging pharmaceutical industry's narrative.43:12 - Drug companies often underreport side effects of medications.45:08 - Tips for cooking and storing meats more effectively.48:38 - Concerns about cholesterol levels and CAC scores require more detailed health information.50:34 - Understanding baseline health metrics is crucial for interpreting dietary changes.53:53 - Contextual understanding is essential for evaluating health issues.55:52 - Food labelling often misleads consumers about ingredients.59:24 - Discussion on channel updates and audience engagement strategies.

Immediately after the Potomac reunion, Kiki Monique joins me to chat about this hilarious and entertaining first part. We additionally touch on last weeks Southern Charm and Summer House.Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFollow Kiki: https://www.instagram.com/thetalkofshame/?hl=enListen to Reality Checked: https://www.siriusxm.com/blog/tag/reality-checkedFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

They also discuss safe, realistic strategies that support joint health, including tailored exercise and strength training, plus the emerging evidence on GLP-1 medications (like semaglutide/Ozempic/Wegovy) for people with obesity and arthritis. The key message: obesity is a treatable chronic condition, and care should be compassionate, individualized, and evidence-based.*Content note/ trigger warning: This episode includes discussion of body weight, obesity, BMI, and weight-loss medications (including GLP-1 drugs).  We approach this topic from a stigma-free, evidence-based perspective, as well as lived experience, but we know conversations about weight can be sensitive or activating, especially for those with a history of weight stigma, eating disorders, or body image challenges. Listener discretion encouraged.Episode at a glance:Weight and arthritis: inflammation + joint load (OA and inflammatory arthritis)Why adipose tissue can worsen pain and disease activityBMI limits: muscle loss, fat distribution, and rheumatoid cachexiaExercise myth-busting: movement helps when it's tailored and gradualStrength training for knee support and better joint mechanicsGLP-1 medications (semaglutide, tirzepatide): what research shows so farStigma-free framing: obesity is chronic, not a personal failurePractical next steps and trusted resources (Arthritis Research Canada webinar)Medical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jay is back yapmaxxing with Kaya about Industry: Dear Henry. What a ride!Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

We start off talking about a man in Louisiana who has been arrested for the 3rd time for deceiving people into changing his diaper, an Army colonel who traded secrets for attention, the weird side effects of GLP-1s and Mounjaro Penis! LINKS:Man poses as disabled so nanny will change his diapers, police sayEx-Army colonel at MacDill shared classified battle plans to woo womanWeight-loss drugs could increase risk of malnutrition-related disease | Fox NewsMan shares experience with ‘Mounjaro penis' that added ‘3 inches' to manhoodThe Treehouse Show is a Dallas based comedy podcast. Leave your worries outside and join Dan O'Malley, Trey Trenholm, Raj Sharma, and their guests for laughs about funny news, viral stories, and hilarious commentary.The Treehouse WebsiteGet MORE from the Treehouse Show on PatreonTreehouse YouTube ChannelGet a FREE roof inspection from the best company in DFW:Cook DFW Roofing & Restoration CLICK HERE TO DONATE:The RMS Treehouse Listeners Foundation

Join bariatric surgeon Dr. Bethany Briggs as she discusses the latest advancements in bariatric surgery, including the role of GLP1 medications in weight loss management. Understand how advancements make surgery safer and more effective, and discover the multidisciplinary approach to treating obesity. Tune in for expert insights and practical information!  Learn more about Bethany Briggs, DO 

(Part two) Welcome to another episode of Bravo We're White with Ryan Bailey. Kaya and Ryan sit down for the most ADHD symptomatic chat in a minute and it was so fun that it had to be split into two! This is part two!List of subjects include:T Shirt of the WeekMaga WivesBatman and RobinRise and Fall of Reggie Dinkins So much more!Make sure you listen to So Bad It's Good here: https://open.spotify.com/show/2gkRNYPqUILEHhezZY0C8dSubscribe to his Patreon here: https://www.patreon.com/sobaditsgoodAlso, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Welcome to another episode of Bravo We're White with Ryan Bailey. Kaya and Ryan sit down for the most ADHD symptomatic chat in a minute and it was so fun that it had to be split into two! Come back for part 2 tomorrow. List of subjects include:T Shirt of the WeekMaga WivesBatman and RobinRise and Fall of Reggie Dinkins So much more!Make sure you listen to So Bad It's Good here: https://open.spotify.com/show/2gkRNYPqUILEHhezZY0C8dSubscribe to his Patreon here: https://www.patreon.com/sobaditsgoodAlso, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Send a textWhat happens when weight loss becomes… easy?In this candid conversation, I sit down with a fellow therapist and friend Lucy Cavendish who has been taking Mounjaro (a GLP-1 medication) and has experienced significant weight loss. We explore the undeniable benefits of these injections — reduced appetite, quieter food noise, and the relief of finally seeing the scale move.But we don't stop there, we ask the deeper questions:What role did emotional triggers play in the weight gain to begin with?What happens when the injections stop?Can changing your body change how you feel about yourself?And how do we prevent old coping mechanisms from creeping back in?This episode isn't anti-medication. It's about integration.GLP-1s like Mounjaro can be powerful tools. But sustainable change often requires understanding the story behind the weight — the stress, grief, trauma, burnout, habits, identity shifts — and making sure those triggers aren't waiting quietly in the background.If you're considering these injections, currently taking them, or navigating weight loss while working on your relationship with food and your body, this episode will help you think beyond the scale.Because sometimes losing weight is the easy part.Understanding it is the real work.Thanks for listening, I hope this episode will be helpful.Philippe

TELL ME LIES IS STRESSING US THE HELL OUT IN THE BEST WAY! Listen to Bitch is Better: https://podcasts.apple.com/us/podcast/bitch-is-better/id1496516498Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

In a very Black episode, the core four unite to talk about College Hill -- the season with Lesa Milan in it! Raven so graciously allowed Kendrick and Kaya and Aaron to give you guys the first episode for free! If you want to hear the rest of this chaos weekly, you'll have to go to Raven's Patreon where it will also be in video format!Listen to Bitch Is Better: https://podcasts.apple.com/us/podcast/bitch-is-better/id1496516498Listen to I Ken Not: https://podcasts.apple.com/us/podcast/i-ken-not-with-kendrick-tucker/id1525311067Subscribe to Raven's patreon: https://www.patreon.com/bitchisbetterAlso, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

It's projected that nearly 18% of households in the U.S. have at least one individual using GLP1 drugs. That's a trend that's expected to continue, and it has implications for production agriculture. Consumers have cut consumption of many food items, and increased in others. Ben Jarboe finds out how food grade soybeans are handling the adjustments from Scott Sinner the VP of Supply Chain with SB&B foods. Sinner says right now things look bright, and they're hoping the sentiment grows! Sunshine back in the forecast today with above normal temps. Stu Muck says that trend shouldn't change through the weekend. A coalition including agricultural groups gathered just off the square to discuss the price tag the state's been presented for SNAP, known as FoodShare in the state. Stephanie Hoff reports from the Capitol. Approximately 165 entities including the WI Cheesemakers Assn., state Potatoe & Vegetable Growers and WI Pork spoke up on the need for the program. Aside from ensuring families have adequate access to fresh, nutritional food, the program provides certainty for Wisconsin farmers. Rebecca Sweeney, senior director of programs and policy for the WI Cheesemakers Assn. says 8-10% of all FoodShare dollars spent in the state go toward dairy products. She notes that even a 5% drop in grocery store sales would create financial pressure for farmers, food processors and agribusiness. Beef is one of the brighter elements of production agriculture today, but you can always learn something new. Dr. Amy Radunz, animal nutritionist and past president of the WI Cattlemen's Association, says hearing from growers outside the state is helpful. That's why they've invited Tucker Brown, a cattle producer and agriculture advocate from Texas, to share what works for him - and might work in Wisconsin. Too much milk. We're hearing it from analysts, processors and industry leaders. Despite the volume challenges, there's more to come! Jenny Wackershauser, dairy analyst with EverAg in Platteville, says that "spring flush" is just around the corner with more milk cows having calves and coming back into full milk production. Where's it going to go? What's it going to do to prices, and do you have risk management tools in place to protect your operation. She joins Pam Jahnke with some strategies.See omnystudio.com/listener for privacy information.

Preston Read A Bish Down Mitchum from Black Summer House joins Kaya to talk about Traitors! But first, of course Kaya has to ask the question: Is Summer House Martha's Vineyard ever possibly coming back?Make sure you follow Preston across all social media:@preston.mitchumhttps://prestonmitchum.com/contactAlso, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Introduction — Are GLP-1 Drugs Forever?Have you heard experts say that GLP-1 medications like Ozempic, Wegovy, or Zepbound are forever drugs — because once you stop, you regain all the weight?I'm not fully convinced that's true.I've found three promising approaches being developed that may help people stop medication without immediate weight regain.Each approach is completely different:One focuses on the stomachOne on the brainOne on structured lifestyle interventionI'm Dr. Gary Pepper. I've practiced endocrinology for over 30 years. This podcast is unsponsored, and I receive no financial compensation from the treatments discussed. This content is educational only and not a substitute for medical care from your physician.Chapter 1 — Resetting the Gut (DMR)The first approach is called Duodenal Mucosal Resurfacing (DMR).The theory is that while you're on GLP-1 medication, the part of the stomach that normally produces appetite-regulating hormones becomes dormant. After long enough, it may struggle to restart when medication stops.DMR removes the top layer of the stomach lining using a heated endoscope. This forces regeneration of fresh cells that produce appetite-controlling hormones.In a short three-month study, patients who underwent the procedure did not regain weight after stopping medication — some continued to lose.This sounds dramatic, but the technique is already FDA-approved for other stomach conditions. It is not yet approved for weight management, but it shows where research is heading.Chapter 2 — Retraining the Brain (rTMS)The second approach targets the brain instead of the gut.It's called Transcranial Magnetic Stimulation (rTMS) — already used for depression treatment.Magnetic coils stimulate appetite control centers in the brain. After just five weeks of treatment, participants lost as much weight over a year as those taking semaglutide for a full year.This is early research, but it suggests appetite control may eventually be trained neurologically rather than chemically.Chapter 3 — Exercise as Hormone RehabilitationThe third approach is the most practical and immediately available: structured exercise.Researchers at the University of Copenhagen studied people stopping GLP-1 medication after a year of use.Those who followed a structured program of resistance and cardio training regained almost no weight — averaging about five pounds over a year.Those returning to sedentary habits regained most of their weight.Exercise appeared to restore the body's natural GLP-1-like hormone production.This is not about willpower.It's biological rehabilitation.Closing — A Changing LandscapeThese three approaches show that weight regain after GLP-1 is not inevitable.The science is evolving quickly.I'll continue tracking new developments and sharing updates here.Thanks for listeninGary Pepper, M.D., an associate professor at a prominent medical school and endocrinologist with 40 years of experience, brings clarity to numerous topics within the field of metabolic health. His view points are unhindered by corporate interests, unlike many other current "thought leaders" in medicine. Dr. Pepper, a dedicated educator, established his homebase website www.metabolism.com in 1996 and has blogged on important topics since then. Not one to be left behind by technology he began podcasting in 2020 with the onset of the pandemic and continues publishing vlogs on YouTube at his channel metabolism123. So whatever your choice in media, you will be gaining fresh insights by tuning in to his opinionated shows or reading his blogs on critical health topics.

Kendrick returns to talk Industry! From Rishi's antics to Sweetpea supremacy - we have a lot to discuss with our mid season check in. Make sure you check out I Ken Not and rate it five stars: https://podcasts.apple.com/us/podcast/i-ken-not-with-kendrick-tucker/id1525311067Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Sometimes it's humiliating to be a woman. Especially a woman watching reality TV. In an episode that got so off course, Kaya rearranges the sequence she talks about the shows in so you can have a little fun at least while she talks about The Valley Persian Style and Southern Charm, things then take a pissed off turn.Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Just two Black women who love Meghan Markle, storytelling and relatable superheroes talking for the first time about all the above! Make sure you watch Wonder Man on Disney Plus and if you haven't already With Love, Meghan. Follow Erin on Instagram: https://www.instagram.com/erinjoneswesley/?hl=enPlay along to a gamefied Beverly Hills: https://www.erinjw.com/Listen and rate the Like Us Pod 5 stars: https://podcasts.apple.com/us/podcast/like-us-pod/id1811274673Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Raven returns for our Tell Me Lies coverage and it's a good ole time!Listen to Bitch Is Better here: https://podcasts.apple.com/us/podcast/bitch-is-better/id1496516498Also, y'all I got you with a code for ro.co for a GLP1! Baby you can get it in pill form now!Join Ro Body: ro.co/BRAVOBLACKWant to contribute to Black creatives during Black History Month: https://buymeacoffee.com/bravowhileblackFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Send us a textDemand for GLP-1 medications has exploded in recent years. What started as a diabetes treatment has quickly become one of the most talked-about forces in healthcare, reshaping how we think about obesity, metabolic disease, access, affordability, and long-term care.But with rapid growth comes confusion: questions about safety, cost, supply constraints, and whether the current system is actually capable of supporting patients for the long haul.Dr. Myra Ahmad, Founder and CEO of Mochi Health joins CareTalk host David E. Williams to discuss what's getting lost in the GLP-1 conversation, why most care models are not built for long-term obesity treatment, and how Mochi is approaching physician-guided metabolic care at scale.

The Deadly Price of Being Thin: GLP-1s, Wegovy & the Weight Loss Trap Why are people literally dying to be thin? In this eye-opening episode of The Karel Cast, we dive deep into the dangers behind the newest weight-loss craze—GLP-1 drugs like Wegovy and Ozempic. While they promise miracle results, these injections are linked to serious side effects, including hundreds of deaths. From the dark history of Fen-Phen and Dexatrim to today's injectable solutions, we expose the medical risks, the psychological toll, and the false hope sold to millions who simply want to lose 30 or 40 pounds. Is being thin worth risking your pancreas, gallbladder—or your life? PLUS: It's time to talk about E-scooters, E-bikes, and other mobility devices that are flooding public spaces and hospitals. Who's regulating them? And what can we do about the growing risks?

מה קורה כשיזם ישראלי בונה חברה של מיליארד דולר במכירות שנתיות בארה"ב ואז עוזב הכל כדי להתחיל מחדש? אלון מטס, מייסד Better Help שהגיעה להכנסות של 1.1 מיליארד דולר, חוזר לספר על המעבר המפתיע שלו לעולם הקואצ'ינג עם Strawberry - והפעם הוא משלב בינה מלאכותית בתהליכי קואוצ'ינג. שוחחנו כמובן גם על "הדעות הלא פופולריות" שלו ביחס להתאגדות בישראל, גיוס, הערכת שווי, ועוד. פתיחה והכרות עם אלון מטס - 0:00הסיפור האישי של אלון ומעבר לארצות הברית - 0:57הקמת Better Help ופיתוח פלטפורמת הטיפול המקוונת - 2:01המעבר מ-Better Help לסטראברי והחזון החדש - 3:25גיוס הכסף לסטראברי ושיתוף עם אורן זאב - 5:49הסיפור האישי של ירידה במשקל והשימוש בזריקות GLP1 - 11:00הפילוסופיה של שיתוף אישי ויתרונותיו - 12:20המעבר לעולם הקואוצ'ינג והבדלים מתרפיה - 18:28הגישה של מרקטפלייס ותעדוף הקונסומר על הפרובייד - 22:36השינוי שחולל קוביד על תעשיית הטיפול המקוון - 25:15הטכנולוגיה של AI בקואוצ'ינג וה-Augmented Intelligence - 32:40דעות לא פופולריות על התאגדות בישראל מול ארצות הברית - 42:00גיוס כסף - למה כדאי לגייס כמה שיותר בסיד - 52:40הבעיה עם פאונדר פיינדרס והאם זה לגיטימי - 58:04הטעות הגדולה של יזמים - התאהבות בבעיה אישית - 1:02:25

PRE-ORDER the upcoming book now: https://www.holisticlifenavigation.com/the-bookThe new Food Pyramid is released in the United States, turning the old one on its point. Regardless of how you feel about the administration it is released under, the focus has shifted from carbs and demonizing fats to centering protein, vegetables, nuts, beans and healthy fats. Camille reminds us that it is a guideline, not a hard and fast rule, because diverse bodies have diverse needs. And, she reminds us, science is always evolving, and should be questioned, so this will not be the last food pyramid. Luis is excited about the shift because so many illnesses, such as diabetes, high cholesterol, anxiety and cognitive decline can be traced to excess glucose, a byproduct of all those refined cards we were told to eat in the old mythology (funded by cigarette companies). All those ultra processed foods leave us with less macro-nutrients, therefore less nourished, and with less GLP1 in the body telling us when are a satiated. At first glance eating a balanced whole foods diet might seem more expensive, but considering long term health consequences and quality of life impacts, the balanced approach is economical. Gleefully, beans hold rank in the new pyramid. Luis and Camille indulge some excitement over this point. They also discuss grass-fed versus mass produced meat, what they think of the inclusion of dairy, and the proportions that are recommended. Dive in to geek out with Luis and Camille as they explore this new dietary recommendation. You can view the updated Food Pyramid PDF here: https://cdn.realfood.gov/DGA.pdfYou can register for the FREE Food Therapy session here: https://www.holisticlifenavigation.com/events/nutrition-for-your-kids You can read more about, and register for, Camille's Embodying My Cycles & Rhythms 6-month group here: https://www.holisticlifenavigation.com/cycles-and-rhythms-slow-group You can read more about, and register for, the retreat at Blue Spirit Costa Rica here: https://www.holisticlifenavigation.com/blue-spirit----You can learn more on the website: https://www.holisticlifenavigation.com/ You can follow Luis on Instagram @holistic.life.navigationQuestions? You can email us at info@holisticlifenavigation.com

GLP-1 medications are everywhere right now-and if you're a woman over 40, chances are you've considered one, are currently taking one, or know someone who is.But here's the conversation that's missing:What happens to your muscle when appetite drops and weight comes off quickly?In this episode, we're talking about why strength training is non-negotiable for women 40+ taking GLP-1s-and how skipping it can impact your metabolism, energy, body composition, and long-term results.This is not an anti-GLP-1 conversation.It's a pro-muscle, pro-strength, pro-health-after-40 one.You'll learn:How GLP-1s can contribute to muscle loss if strength training isn't part of the planWhy walking and cardio alone aren't enough to protect your metabolism in midlifeThe role protein plays when appetite is low (and why it matters more-not less)What smart, sustainable strength training looks like while on a GLP-1Why the real goal isn't just weight loss-it's body composition, strength, and confidenceIf you want results that last—and a body that feels strong, capable, and energized-this episode will help you train smarter and protect what matters most.

Ashley Koff, RD is the founder of The Better Nutrition Program (BNP) and the author of the upcoming book, Your Best Shot (Harper One, January 6, 2026). A practitioner for over 25 years, Koff is leading a transformative movement in personalized nutrition, turning “better, not perfect” choices into practical, sustainable strategies that deliver real health outcomes. Through patient stories and personal experience, she shows that optimal health is not just possible—it's essential to living your fullest life. Koff has been recognized as one of CNN's Top 100 Health Makers, featured in InStyle as “Hollywood's Leading Dietitian,” and has been selected as Westin's Global Nutrition Ambassadorhttps://thebetternutritionprogram.com/________________________________________________________________________________________Join The Buff Muff Method https://get.buffmuff.com/methodRejuve is a line of pelvic health and whole body health supporting supplements that are helping women have a daily poogasm, eliminate leaks and prolapse symptoms, and keep their vulvovaginal tissues supple and resilient. Get your Rejeuve Supplements https://rejeuve.com/ and use code Podcast to save 10% off your first order.Thank you so much for listening! I use fitness and movement to help women prevent and overcome pelvic floor challenges like incontinence and organ prolapse. There is help for women in all life stages! Every Woman Needs A Vagina Coach! Please make sure to LEAVE A REVIEW and SUBSCRIBE to the show for the best fitness and wellness advice south of your belly button. *******************I recommend checking out my comprehensive pelvic health education and fitness programs on my Buff Muff AppYou can also join my next 28 Day Buff Muff Challenge https://www.vaginacoach.com/buffmuffIf you are feeling social you can connect with me… On Facebook https://www.facebook.com/VagCoachOn Instagram https://www.instagram.com/vaginacoach/On Twitter https://twitter.com/VaginaCoachOn The Web www.vaginacoach.comGet your Feel Amazing Vaginal Moisturizer Here

Send us a textAre GLP-1 drugs becoming a long-term foundation of healthcare? In this clip from our episode "What JPM Signals for Healthcare in 2026", CareTalk hosts David Williams and John Driscoll discuss why GLP-1s may be evolving beyond short-term weight loss treatments.Listen to the full episode here

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: (Stacey Track) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. We are less than one month from our first MNO of 2026. Please join us in Silver Spring MD Feb 20 and 21. It's going to be amazing. We're going to Nashville next March 6-7 and we're going to have a great event a Club 1921 we just added on Thursday March 5th for health care providers and patient leaders. All the info is over at diabetes-connetionss.com events/ Okay.. our top story this week: XX   All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. This is the ELSA study - Early Surveillance for Autoimmune diabetes, a first of its kind UK study. They tested blood samples from 17,931 children aged 3-13 for autoantibodies, markers of type 1 diabetes that can appear years before symptoms. Families of children found to have early-stage type 1 diabetes received tailored education and ongoing support to prepare for the eventual onset of type 1 diabetes symptoms and to ensure insulin therapy can begin promptly when needed, reducing the chances of needing emergency treatment. Those with one autoantibody also received ongoing support and monitoring.   Some families were also offered teplizumab, the first ever immunotherapy for type 1 diabetes, which can delay the need for insulin by around three years in people with early-stage type 1 diabetes. The second phase has launched and will expand screening to all children in the UK aged 2-17 years, with a focus on younger children (2-3 years) and older teenagers (14-17 years). The research team aims to recruit 30,000 additional children across these new age groups. ELSA 2 will assess how screening can be scaled across the NHS and evaluate its cost-effectiveness. https://www.birmingham.ac.uk/news/2026/childhood-type-1-diabetes-screening-is-effective-and-could-prevent-thousands-of-emergency-diagnoses XX At the J.P. Morgan Healthcare Conference Dexcom CEO Jake Leach says they're going to launch a new product outside the US. I'll link up that interview, The full quote: "When you look at the outside the U.S., there are a lot of structures that are tiered. Patients have access to different types of products, so we've got a new one that we want to introduce that will add flexibility there. It's based on the G7 platform, just like Dexcom ONE+, but it has a unique experience that's tailored for a subset of users that, today, don't have access to Dexcom." Your guess is as good as mine, but sounds more like a pricing or ordering issue than a new bit of hardware or software. Dexcom will also bring Stelo to some international markets this year. And plans a new mobile app experience for the wearable biosensor meant for people who don't dose insulin. Leach also says G8 will be much smaller and with more capability. but is a few years away. https://www.drugdeliverybusiness.com/dexcom-ceo-jake-leach-2026-roadmap-jpm/ XX A new international consensus statement provides guidance for the use of diabetes technology during pregnancy for women with type 1 diabetes (T1D), type 2 diabetes (T2D), or gestational diabetes (GD).   Organized by the diaTribe Foundation, the document was based on evidence where available, as well as opinion from an international group of experts in endocrinology, diabetes technology, and obstetrics & gynecology, among others.   This is the first set of recommendations specifically addressing the use of diabetes technology in pregnancy – and we'll link it up. https://www.medscape.com/viewarticle/new-consensus-statement-addresses-diabetes-tech-pregnancy-2026a100020d XX Bariatric surgery beats GLP-1s for type 2 diabetes across income levels. This study was published this month, looking at nearly 300 patients are 4 medical centers. Success here is measured by lower blood glucose levels, higher weight loss (28% vs. 10%), less use of diabetes medications, remission of diabetes to the point of no longer needing to inject insulin, and reduced risk factors for cardiovascular disease.     Bariatric surgery was better than medical therapy across all social backgrounds, they found, and not just in areas of higher deprivation. The ancillary study was smaller, and some of the participants randomized in earlier stages crossed over from medical to surgical treatment, and the reverse. The authors acknowledged and accounted for these limitations, along with the rapid development of more powerful obesity drugs not fully captured in the study. This was a long term study – more than 12 years – and by the end of the study more people were choosing GLP1 medications. One dividing line: If someone hopes to lose 100 pounds, that's more likely with surgery than with medications.  "Ultimately, we need large, long-term, well-designed studies to clarify the best strategy for a given patient." https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ XX Researchers at the University of California, Riverside have reported for the first time that a father's exposure to microplastics (MPs) can lead to metabolic problems in his children, including diabetes. This is a mouse study, but it looks at a previously unrecognized way in which environmental pollution may influence the health of future generations. MPs are extremely small plastic fragments, measuring less than 5 millimeters, that form as consumer products and industrial materials break down. Metabolic disorders describe a group of conditions that include elevated blood pressure, high blood sugar, and excess body fat, all of which raise the risk of heart disease and diabetes. The team found that female offspring of male mice exposed to MPs were far more prone to metabolic disorders than offspring of unexposed fathers, even though all offspring received the same high fat diet.     The research team hopes the findings will guide future investigation into how MPs and even smaller nanoplastics affect human development.   https://scitechdaily.com/microplastics-can-rewire-sperm-triggering-diabetes-in-the-next-generation/ XX The FDA has finalized four new recalls for certain lots of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to ongoing safety concerns. We told you about this in November when Abbott says some of its continuous glucose monitoring (CGM) sensors were providing incorrect low glucose warnings. Internal testing identified the issue—carbon building up in the sensors during the manufacturing process—and determined that approximately 3 million CGM sensors were affected. The sensors were distributed in the United States, Canada and several European countries.  When Abbott shared that announcement, the FDA was still reviewing the situation. No recalls had yet been finalized. Now, however, the agency has announced four new Class I recalls.   https://cardiovascularbusiness.com/topics/clinical/heart-health/fda-confirms-recalls-abbott-cgm-sensors-new-lawsuit-alleges-company-concealed-information XX   Insulet brings back it's U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products. Insulet began recycling pilot programs in Mass and California and are rolling it out nationwide. Insulet also has "Pod takeback" programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.   https://www.drugdeliverybusiness.com/insulet-expands-us-pod-recycling-program/ XX Up next a new resource for a population at three times the risk for diabetes, but without a lot of access to health information. I The first diabetes information website primarily in ASL has launched. The site includes GIFs and videos on diabetes management and an ASL glossary of diabetes-related terms. This is from University of Utah Health – Called Deaf Diabetes Can Together. Deaf and hard of hearing people are at three times higher risk for diabetes, but access to health information in ASL is limited. https://healthcare.utah.edu/newsroom/news/2026/01/first-diabetes-information-website-asl-launches XX Novo Nordisk ended all work on cell therapies, including a Type 1 diabetes program, in October – and now has found a buyer. Aspect has acquired rights to the assets and giving Novo an option to reengage for later-stage development and commercialization. Novo is helping bankroll Aspect's development of the assets, investing in the company and providing research funding. The arrangement gives Novo a chance to profit from the programs down the line. Novo is eligible for royalties and milestone payments on future product sales and, having handed the reins to Aspect for now, can expand its role in later-stage development and commercialization. The integration will involve the transfer of capabilities and expertise from Novo sites in Denmark and the U.S. to Aspect's Canadian operations. https://www.fiercebiotech.com/biotech/novo-nordisk-offloads-diabetes-assets-aspect-amid-cell-therapy-retreat XX XX Lucas Escobar has carved a role by proving that healthcare marketing can be culturally resonant, commercially powerful and deeply human. As director and head of U.S. consumer marketing at Insulet, he has redefined how the Omnipod tubeless insulin pump shows up in culture, transforming a medical device into a symbol of identity, inclusion and empowerment.   Under Escobar's leadership, Insulet launched three breakthrough initiatives: Dyasonic: Sound of Strength, a Marvel comic collaboration introducing a superhero who uses Omnipod; The Pod Drop, which turned the sound of a pod change into a celebratory music track; and Omnipod Mango x Pantone, medtech's first color partnership, honoring the vibrancy of the diabetes community. Each blended creativity with purpose while driving results, helping fuel Omnipod's consistent double-digit growth and its position as the most prescribed insulin pump in the U.S.   Living with type 1 diabetes himself, Escobar brings lived experience to his work, using storytelling not just to sell, but to make people feel seen.   Click here to return to the 2026 MM+M 40 Under 40 homepage.   From the January 01, 2026 Issue of MM+M - Medical Marketing and Media https://www.mmm-online.com/40-under-40/40-under-40-lucas-escobar-insulet/ -- FDA approves an update to the prescribing info for Afrezza inhaled insulin. This is a revision to the recommendations for the starting mealtime dosage when patients switch from shots or insulin pumps. This is aimed at healthcare providers - the updated labeling was supported by results from the INHALE-3 trial. The FDA is still considering approval of Afrezza for kids – a decision there expect by summer. https://www.globenewswire.com/news-release/2026/01/26/3225442/29517/en/MannKind-Announces-FDA-Approval-of-Updated-Afrezza-Label-Providing-Starting-Dose-Guidance-when-Switching-from-Multiple-Daily-Injections-MDI-or-Insulin-Pump-Mealtime-Therapy.html   -- UK researchers have developed a calculator to predict whether someone is at risk for type 1 diabetes. They're hoping this helps in screening and in preventing DKA at diagnosis. They used the TEDDY study to create this calculator, which right now is in beta form and only for kids and teens ages 8-18. The current beta form of the calculator asks users to answer questions about four factors necessary to estimate a child's risk of developing type 1 diabetes: age, family history, number of confirmed autoantibodies, and genetic risk score. The calculator has been given regulatory approval as a diagnostic in the U.K., and he's working with a company that's hoping to bring it to the U.S. in the next few months in the form of a home genetic test kit. https://www.healthcentral.com/news/type-1-diabetes/new-calculator-might-help-predict-type-1-diabetes-before-symptoms-appear

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________This isn't medical advice — always talk to your doctor before making any health decisions.“What do I eat in a day?” is one of the most common and most searched questions people ask when starting a GLP-1. In this episode, we're joined by Ana Reisdorf, MS, RD, registered dietitian and host of the GLP1 Hub Podcast, to explore how nutrition support fits into GLP-1 treatment in the real world. We talk through Ana's lived experience with weight, the difference between dietitians and nutritionists, and why many patients are left without practical guidance once a prescription is written.The conversation focuses on the growing gap between physician time constraints and patient needs, and how dietitians who understand and support GLP-1s are uniquely positioned to bridge it. We break down macros in accessible terms, discuss nutritional balance beyond protein, and examine how resting metabolic rate, sleep, appetite regulation, and tracking all influence daily intake, especially for those with a history of food or body trauma. This episode highlights why GLP-1-informed dietitians may play a central role in the future of sustainable, patient-centered obesity care.Professional/Community  Guest:Ana Reisdorf MS, RDGLP1 Hub Podcast Links GLP1Hub PodcastApple  PodcastSpotify YouTube WebsiteInstagram ______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Send us a textAI, GLP-1s, federal policy, and China. Those themes dominated last week's JP Morgan Health Care Conference in San Francisco. But what, if anything are the implications for the broader healthcare world in 2026?Hosts David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health discuss what stood out most at JPM, including why the GLP-1 wave may be entering a new phase, how Big Tech and AI are reshaping the healthcare landscape, and why China's growing presence in biotech is becoming harder to ignore.

Jillian Michaels flies solo—and holds nothing back. In this explosive episode, Jillian dismantles the media narrative surrounding the tragic shooting of Renee Goode by ICE officer Jonathan Ross. While politicians and pundits whip the public into tribal hysteria—branding people as “villains” and “terrorists”—Jillian cuts through the noise to expose the real forces fueling the violence. This isn't incompetence. It's strategy. A cynical game of political chess where human lives are expendable collateral. Then she turns her fire on Oprah Winfrey. Is obesity really genetic—or is that a comforting lie designed to keep you dependent, medicated, and profitable? Jillian breaks down the science they don't want you to hear, dismantles the “shame-free” marketing narrative, and exposes the financial conflicts of interest behind the sudden moral rebrand of weight-loss drugs. From Ozempic to Big Food to Big Pharma, this is how the system keeps you sick—and sells you the cure. No platitudes. No safe opinions. Just facts, incentives, and uncomfortable truths. In this episode, Jillian exposes: The ICE Shooting Investigation. Why federal agencies are sidelining local investigators. Blue City Chaos: How reckless language from top politicians escalates into real-world violence. The Ozempic Conflict: Oprah's financial entanglements behind the new “genetic destiny” storyline and GLP1 drugs. The BLISS POINT: How the “food” was engineered to hijack satiety and drive addiction. Big Tobacco's Takeover: How cigarette giants bought the food industry and applied the same addiction science. The Science of Fat Loss. Why the First Law of Thermodynamics still applies—no matter how it's marketed. The REAL REASON Why 74% of Americans Are Overweight. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textSupport the showFor merchandise, podcast and youtube: westankersley.comYou have a limited offer you can use now, that gets you up to 48% off yourfirst subscription or 20% off one time purchases with code WEST20 atcheckoutYou can claim it at:https://magicmind.com/WEST20Join The Patreonhttps://patreon.com/WestankersleyFollow Shaping Success https://shapingsuccesspodcast.buzzsprout.com/Get Ars Victorioushttps://a.co/d/5f4todGhttps://a.co/d/5f4todGEmail Wes@westankersley.com for guest ideas or to be on the show!

In this short, five-ish minute episode, I explore how the question so many of you have asked yourself: Should I do a GLP1? This episode walks through the 3 questions that might help you make the decision. I call these million dollar questions, because answering them helps you create million dollar results: weight loss results that actually last, because while a GLP1 might be a part of your toolbox, on it's own it isn't a magic bullet. Our intention on this corner of the internet is to destigmatize your approach and give you an arsenal of tools that helps you feel your best on the scale and off.   Doors for Burn Stress, Lose Weight are closing this week. Connect with us: Email: info@theunstoppablemombrain.com Book your consult here: https://burnstressloseweight.com/group Or send us a DM over on instagram: https://www.instagram.com/burnstressloseweight/  

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)What gets overlooked when we talk about weight, health, and body image?In this episode, we explore the emotional, social, and medical realities of living in a larger body—beyond the scale or appearance.My guest is Dr. Megan Tierney, a family physician, obesity medicine specialist, and founder of Sol Health and Wellness in Seattle. She supports women navigating perimenopause, menopause, and metabolic health changes with care that blends medical management, mindfulness, and self-compassion.We cover:Living in a Larger Body: What Often Gets Missed – The everyday challenges, hidden stress, and societal pressures people in larger bodies face.Choosing What Feels Right for Your Body – How to make intentional health choices while respecting your body and autonomy.Making Space for Bodies to Change – Why body positivity isn't about staying the same and how to honor body evolution.Why Weight Is Not Just Willpower: The Role of Trauma in Health – How trauma, stress, and environment shape our relationship with weight.Living Better, Not Just Lighter – Focusing on overall well-being, mental health, and thriving beyond the numbers on a scale.This episode offers practical insights, compassionate guidance, and strategies to navigate health, body image, and self-care in today's complex world. Whether you're exploring your own journey or looking to better understand these challenges, this conversation is full of clarity, support, and actionable takeaways.Connect with Dr. Tierney :Facebook: Meghan Tierney and Sorrel Health and WellnessInstagram: meghantierneymd and sorrelhealthandwellnessYouTube: Sorrel Health and WellnessLinkedin: Meghan Tierney, MD DABOM, MSCPConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

This week on No Need For Apologies, Dave and Derek welcome comedian Mia Jackson for an episode that somehow goes from movie theater butter to tall-people oppression, with side quests into viral videos, GLP-1 weight loss chaos, Michael Jackson gangsta rumors, and a classic round of “How Black AF1 Are You?”Mia talks life on the road with Amy Schumer, surviving comedy as a tall woman, and whether heels are still an option when you're already towering over everyone. The crew debates if low-hanging branches are a hate crime, why ties are impossible for tall men, and whether you should sit down to moisturize.Plus: – Viral Dr. Pepper jingles – Chuck-E-Cheese truthers – Tall people meetups – Whole Foods staffing conspiracies – Apologies we definitely shouldn't be makingThis episode is for tall people, short tempers, comedy fans, and anyone who owns black Air Force 1s.GO TO http://hellofresh.com/noneed10fm TO GET 10 FREE MEALS + A FREE ZWILLING KNIFE.LIKE, SHARE & SUBSCRIBE https://www.youtube.com/channel/UCLAUp-4rTF4q4XLujbJ51YQ TOUR DATES https://www.linktr.ee/nnfaMERCH https://nnfa.creator-spring.com/ BONUS CONTENT https://www.patreon.com/c/ImDaveTemple?utm_medium=clipboard_copy&utm_source=copyLink -----------------Follow host Derek GainesIG https://www.instagram.com/thegreatboy/ Follow host Dave TempleIG https://www.instagram.com/imdavetemple/ YouTube https://www.youtube.com/@DAT46Follow Mia JacksonIG https://www.instagram.com/miacomedy/ Follow No Need for ApologiesIG https://www.instagram.com/nnfapodcast/ TT https://www.tiktok.com/@noneedforapologies FB https://www.facebook.com/noneedforapologies/Produced by Teona SashaIG https://www.instagram.com/teonasasha/TT https://www.tiktok.com/@teonasasha -----------------To advertise your product on our podcasts please email jimmy@gasdigitalmarketing.com with a brief description about your product and any shows you may be interested in advertising on.SEND US MAIL:GaS Digital StudiosAttn: NNFA151 1st Ave # 311New York, NY 10003"No Need for Apologies" - NEW Episodes every Saturday at 3PM/ET on YouTube-----------------See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Colleen Cutcliffe, CEO and Co-Founder of Pendulum joins Krista to spill the latest on GLP-1, natural metabolic boosters, and why your gut might be begging for a serious upgrade. If sugar cravings or post-meal crashes have you in a chokehold, this episode is for you!Morning Microdose is a podcast curated by Krista Williams and Lindsey Simcik, the hosts and founders of Almost 30, a global community, brand, and top rated podcast.With curated clips from the Almost 30 podcast, Morning Mircodose will set the tone for your day, so you can feel inspired through thought provoking conversations…all in digestible episodes that are less than 10 minutes.Wake up with Krista and Lindsey, both literally and spiritually, Monday-Friday.If you enjoyed this conversation, listen to the full episode on Spotify here and on Apple here.

Michelle & Julian's ThriftingHealthiest breakfast ordersMorons in the news2 Hotel storiesNCAA championship game pricesSad NFL on FoxJunk in MJ's houseMichelle's new FBI Terrorism Task Force shirt$15 million scratcher won in FloridaKiefer Sutherland's ride-share incidentPhoto - Rules for Carrie Underwood appearanceWhat's the issue with Angelina Jolie's finances?Oprah on GLP1 drinks a lot of waterBlake Shelton on rumors of split with Gwen StefaniPooping in an aisle in a storeAnxious fliersA.I. food delivery fraudFast food worker threatens to kill coworkerFester's mattressGreenland/Greenland 2Worst states to raise a familyOlympic rugby star Ilona Maher sets a troll straightFood by Tiana - Largest slice of pizzaInfluencer and ER nurse go head-to-head over shirtColor changing nails at CESVillages resident in trouble for moldy drivewayWhich state's residents spend the most on alcohol per capitaWorst selling cars in the USACostco items that make the $65 membership worthwhileSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.